Patients over the age of 1 or with n-myc
amplification should be considered (Stram et aI.,
1996). Purging of autologous marrow or PBPC
has been shown to reduce relapse rates. Current
studies are looking at ways of incorporating 1
131
MIBG therapy, conventional chemotherapy and
high dose chemotherapy with TBI to improve
outcome in this group of patients.